Meng S, Zhang M, Liang L et al.Current opportunities and challenges: genome-wide association studies on pigmentation and skin cancer. Pigment Cell Melanoma Res 25:612-617

Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Pigment Cell & Melanoma Research (Impact Factor: 4.62). 07/2012; 25(5):612-7. DOI: 10.1111/j.1755-148X.2012.01023.x
Source: PubMed


Genome-wide association studies (GWAS) have become a widely used approach for genetic association studies of various human traits. A few GWAS have been conducted with the goal of identifying novel loci for pigmentation traits, melanoma, and non-melanoma skin cancer. Nevertheless, the phenotype variation explained by the genetic markers identified so far is limited. In this review, we discuss the GWAS study design and its application in pigmentation and skin cancer research. Furthermore, we summarize recent developments in post-GWAS activities such as meta-analysis, pathway analysis, and risk prediction.

Download full-text


Available from: Mingfeng Zhang, Nov 01, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although genetic studies have reported a number of loci associated with cutaneous melanoma (CM) risk, a comprehensive synopsis of genetic association studies published in the field and systematic meta-analysis for all eligible polymorphisms have not been reported. We systematically annotated data from all genetic association studies published in the CM field (n = 145), including data from genome-wide association studies (GWAS), and performed random-effects meta-analyses across all eligible polymorphisms on the basis of four or more independent case-control datasets in the main analyses. Supplementary analyses of three available datasets derived from GWAS and GWAS-replication studies were also done. Nominally statistically significant associations between polymorphisms and CM were graded for the strength of epidemiological evidence on the basis of the Human Genome Epidemiology Network Venice criteria. All statistical tests were two-sided. Forty-two polymorphisms across 18 independent loci evaluated in four or more datasets including candidate gene studies and available GWAS data were subjected to meta-analysis. Eight loci were identified in the main meta-analyses as being associated with a risk of CM (P < .05) of which four loci showed a genome-wide statistically significant association (P < 1 × 10(-7)), including 16q24.3 (MC1R), 20q11.22 (MYH7B/PIGU/ASIP), 11q14.3 (TYR), and 5p13.2 (SLC45A2). Grading of the cumulative evidence by the Venice criteria suggested strong epidemiological credibility for all four loci with genome-wide statistical significance and one additional gene at 9p23 (TYRP1). In the supplementary meta-analyses, a locus at 9p21.3 (CDKN2A/MTAP) reached genome-wide statistical significance with CM and had strong epidemiological credibility. To the best of our knowledge, this is the first comprehensive field synopsis and systematic meta-analysis to identify genes associated with an increased susceptibility to CM.
    Journal of the National Cancer Institute 06/2011; 103(16):1227-35. DOI:10.1093/jnci/djr219 · 12.58 Impact Factor
  • Source

    Melanoma - From Early Detection to Treatment, 1 edited by Guy Huynh Thien Duc, 01/2013: chapter Melanoma Genetics: From Susceptibility to Progression: pages 83-136; InTech Books., ISBN: 978-953-51-0961-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: In an earlier genome-wide association (GWA) study and the subsequent replications, three loci located in the melanocortin 1 receptor (MC1R) and TYR genes as well as the regions adjacent to MTAP and CDKN2A were identified to be risk factors for cutaneous melanoma (CM) (Bishop et al., 2009). However, this GWAS study did not cover all the potential genetic risk regions of susceptibility genes. More recently, three additional GWASs identified additional risk loci for CM, including a few SNPs in MC1R (Amos et al., 2011; Barrett et al., 2011; Macgregor et al., 2011). There are a number of SNPs in MC1R that contains only one exon, only a few of which have been included in the published GWASs; therefore, it is necessary to sequence the whole gene to provide a holistic view of the contribution of all MC1R SNPs to risk of CM (Meng et al., 2012). © 2013 John Wiley & Sons A/S.
    Pigment Cell & Melanoma Research 01/2013; 26(3). DOI:10.1111/pcmr.12070 · 4.62 Impact Factor
Show more